131 related articles for article (PubMed ID: 23231733)
1. Successful treatment of scleromyxedema with oral thalidomide.
Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
[No Abstract] [Full Text] [Related]
2. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
3. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
4. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
6. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
7. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
8. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
9. Scleromyxedema with myopathy was successfully treated by thalidomide.
Wu MY; Hong JB; Yang CC; Hu SL; Liao YH
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):189-90. PubMed ID: 18435730
[No Abstract] [Full Text] [Related]
10. Successful treatment of scleromyxedema using thalidomide.
Thyssen JP; Zachariae C; Menné T
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1396-7. PubMed ID: 17062103
[No Abstract] [Full Text] [Related]
11. Letter to the editor.
Abarzúa A; Sandoval M; González S; Giesen L
Int J Dermatol; 2014 Sep; 53(9):1180-1. PubMed ID: 25124465
[No Abstract] [Full Text] [Related]
12. Successful treatment of scleromyxedema with melphalan and dexamethasone followed by thalidomide maintenance therapy.
Cao XX; Wang T; Liu YH; Zhou DB; Li J
Leuk Lymphoma; 2016 Dec; 57(12):2934-2936. PubMed ID: 27118492
[No Abstract] [Full Text] [Related]
13. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
[No Abstract] [Full Text] [Related]
15. Case report: Scleromyxedema associated with a monoclonal gammapathy: Successful treatment with intravenous immunoglobulins.
Wang SS; Chen QY; Xiang LH
Front Immunol; 2022; 13():1099918. PubMed ID: 36713453
[TBL] [Abstract][Full Text] [Related]
16. Scleromyxedema, a positive effect with thalidomide.
Jacob SE; Fien S; Kerdel FA
Dermatology; 2006; 213(2):150-2. PubMed ID: 16902294
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].
Sillard L; Passeron T; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2010 Jan; 137(1):48-52. PubMed ID: 20110069
[TBL] [Abstract][Full Text] [Related]
18. Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.
Peter LM; Ammoury A; Chiavassa-Gandois H; Lamant L; Paul CF
Clin Exp Dermatol; 2008 Aug; 33(5):606-10. PubMed ID: 18477005
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide as a potential treatment for scleromyxedema.
Caradonna S; Jacobe H
Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
[No Abstract] [Full Text] [Related]
20. Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema.
Brunet-Possenti F; Hermine O; Marinho E; Crickx B; Descamps V
J Am Acad Dermatol; 2013 Aug; 69(2):319-20. PubMed ID: 23866873
[No Abstract] [Full Text] [Related]
[Next] [New Search]